Converging Factors Driving the Growth of Dry Powder Inhaled Delivery
The Dry Powder Inhalers Market Report examines the rising potential of dry powder inhalation. This market is being driven by research activity in powder formulations, advances in particle engineering, and the development of novel device architectures. The combination of improved particle properties and more efficient inhaler designs is creating new opportunities for dry powder inhalation and expanding the range of active compounds that can be effectively delivered to the lung via DPI. As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies, inhaled medicine is increasingly being viewed as patient – friendly and cost -effective. Our analysis contained in the dry powder inhalers market report illustrates that inhaled administration in general, and DPI in particular, are well positioned to take advantage of these trends and evolve into a significant factor in the future of pharmaceutical development and the commercialization of therapeutic drugs.
Dry Powder Inhalers Report – Brochure(Download PDF)
Dry Powder Inhalers Report Order Form (Download PDF)
Dry Powder Inhalers to 2024 – What You Will Learn
What inhalable drugs are supplied in powder form, how are they marketed, what are the device specifics, and who markets them?
What inhalable dry powder drugs are in late stage development, who are the developers, and what indications are they targeting?
What are the major factors driving inhaled dry powder drug/device demand?
What is the size of the market today, who are the market share leaders, and what will the market share be in 2024?
How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
What are the essential design factors, technologies and market development issues for dry powder inhalation products?
What are the significant economic, technology, and regulatory factors affecting the market for dry powder inhalers?
Dry Powder Inhalers to 2024 – Summary of Contents
Inhaled Drug Therapeutics
Devices and Formulations
Dry Powder Technology & Markets
Dry Powder Formulations
DPI Product Assessment & Analysis
FDA Approved DPI Products
Dual Drug Products
EMA Approved DPI Products
Dual Drug Products
Therapeutic Segment Analysis, Data & Forecasts